Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Fish and Richardson
US Department of Justice
Boehringer Ingelheim
Harvard Business School

Generated: March 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065123

« Back to Dashboard

NDA 065123 describes MUPIROCIN, which is a drug marketed by Glenmark Pharms Inc, Fougera Pharms, Glenmark Pharms, Perrigo New York, Taro, and Teva, and is included in six NDAs. It is available from twenty-eight suppliers. Additional details are available on the MUPIROCIN profile page.

The generic ingredient in MUPIROCIN is mupirocin. There are thirteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
Summary for 065123
Applicant:Perrigo New York
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 065123
Mechanism of ActionRNA Synthetase Inhibitors
Medical Subject Heading (MeSH) Categories for 065123
Suppliers and Packaging for NDA: 065123
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MUPIROCIN mupirocin OINTMENT;TOPICAL 065123 ANDA Atlantic Biologicals Corps 17856-0112 N 17856-0112-1
MUPIROCIN mupirocin OINTMENT;TOPICAL 065123 ANDA Rebel Distributors Corp 42254-229 E 42254-229-22

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength2%
Approval Date:Nov 7, 2003TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.